PLXS (Plexus Corp.)
All Pro Portfolios with PLXS

People owning PLXS also tend to own:: BWTRCENTCREEEBSGMKTJBLJOBS

All Do-It-Yourself Portfolios with PLXS
  • News For Selected Stock
  • Related stories on theStreet.com
  • videos related to etf's
  • No videos found
  •  
  • blogs related to etf's
  • No blogs found
  •  

Why I Love This Stock

By:barrons3

Date:02 07 09

Sell - Price 14.37 on Feb. 3
by Collins Stewart

Lowering target to 9 (from 10.75)...based on just under 10 times (from 8 times) our calendar '09 pro forma EPS estimate of 91 cents (from $1.36). This P/E is in line with trough multiples in the electronics-supply chain during certain downturns and near current multiples for the [electronics manufacturing service] group. Risks include tech-spending trends, regulation changes and integrating acquisitions. Market cap: $568 million.

Not yet rated
Rate now:

By:barrons3

Date:11 22 08

Q: One more pick, please.

A: Plexus [PLXS], a technology company and a contract manufacturer. They provide product engineering skills, and then will actually manufacture the product for an OEM [original-equipment manufacturer] customer. Plexus has premium levels of profitability in an industry that has relatively narrow margins. They generate pretax margins on a consistent basis of 5% to 7%, in an industry whose average is closer to 2% or 3%. The company has minimal debt, and they've grown steadily over time. They are diversified across a number of sectors, both in computing and networking. Medical is a big market for them in terms of customers. They also make and design products for the industrial market, defense and aerospace. We like the diversification of their portfolio. In their most recent fiscal year, which they just completed, they earned $1.94 a share. The stock is currently around $13. This is just an unusual opportunity to buy a premium company with the financial profile they have, and the know-how that few other companies can match.

Not yet rated
Rate now:

By:Pro

Date:11 30 -1

Credit Suisse said it is downgrading Plexus (PLXS) to Neutral rfom Outperform based on valuation and negative channel checks. Shares are up 20% in past month, and recent checks indicate softening backlog with Juniper post-May. Price target at $30.

Not yet rated
Rate now:

By:sarah z

Date:03 05 08

Contract electronics maker Plexus Corp. said Tuesday its board approved a financial recapitalization, under which it will borrow $150 million to buy back up to $200 million of its common shares.

"Over the last several months we have conducted a comprehensive review of our capital structure, and believe that a moderate amount of debt at the current favorable interest rates strikes the right balance for Plexus," said Chief Financial Officer Ginger Jones in a statement.

Also, Credit Suisse analyst William Stein raised his rating to "Outperform" from "Neutral" on signs that its fiscal second-quarter sales and bookings are better than the company had expected.

The stock trades for 7.5x cash flow.

Not yet rated
Rate now:

By:Pro

Date:11 30 -1

Plexus (PLXS) was upgraded by JP Morgan from Neutral to Overweight.

Not yet rated
Rate now:

By:John Foreman

Date:06 18 07

Electronics maker generates high margins from more than 160 customers.

Return on Assets: 10%
Free Cash Flow (millions): $71

Not yet rated
Rate now:

By:Tom Schoettler

Date:05 09 07

LOW PRICE

Not yet rated
Rate now:

By:kevinkoeppen

Date:05 09 07

Growth

Not yet rated
Rate now:

By:DannyGoh

Date:03 04 07

Turnaround story
Near 52-week low

Not yet rated
Rate now:

By:Pam

Date:02 04 07

YTD % return: -27.60

Not yet rated
Rate now:

Why I Hate This Stock

Comments not available
Add Your Comments  
Stock PLXS
Allowed HTML tags: <a><b><i><img>
  Login to post your comments
Four Must-See Charts: Stem Cell ...

By Stockpickr Staff Posted on July 2, 2009 Developments in the stem cell world are starting to get very interesting. On Tuesday, General Electric (GE) signed an exc...

07.02.09 | 15:19 PM
Stockpickr's Picks of the Day: J...

By Rebecca Corvino Posted on July 2, 2009 Every day, Stockpickr members are creating and sharing stock ideas with each other through various platforms. If you're not al...

07.02.09 | 13:43 PM
Cramer's Take on Headline Stocks...

By Rebecca Corvino Posted at 12:30 p.m. EDT on July 2, 2009 Making Thursday's headlines and sending stocks lower were reports that June saw the loss of 467,000 more job...

07.02.09 | 12:31 PM
Dividend Stocks for the Week

By Stockpickr Staff Posted on July 2, 2009 Some investors assume that at this time of year, it's the summer doldrums for the stock market. After all, as the saying goe...

07.02.09 | 11:02 AM
more articles
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
what happened to DSCO?
07.02.09 | 11:45 AM From author Disco Duck
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
more forums
Q. hgsi lupus drug. results on jul...
07.03.09 | 23:42 PM Asked by 1surfer2

A. the data seems really positive ... I
just read through BioMedReports and
thought it was impressive - the largest
lupus trial ever.

today 's lists
Dogs of the Dow

Here are the 10 stocks in the Dow Jones Industrial Average stocks with the highest yields as of the market close on June 2, 2009. more

TheStreet.com TV Videos

These are some of the stocks mentioned today on TheStreet.com TV. Click the URL below each stock to watch the videos. more

TSC Ratings Upgrades

These stocks were upgraded by TheStreet.com Ratings on July 1, 2009. Check out the full article here.... more